HOME >> BIOLOGY >> NEWS
First new waterborne aquaculture drug in 20 years approved

Twelve years of rigorous research by USGS scientists helped lead to the approval by the Food and Drug Administration (FDA) of the first waterborne drug for fish diseases in more than 20 years.

The drug, 35% PEROX-AID, a product of EKA Chemical, Inc, in Marietta, Ga., was approved recently for use in three diseases of freshwater fish and their eggs that, left untreated, cause significant losses to the $1 billion (2006) U. S. aquaculture industry. State and federal natural resource agencies responsible for fish hatchery programs benefit from more effective and efficient production, including endangered and threatened species broodstock protection, and the public benefits from healthy fish released into the wild for recreation through restoration programs.

Private aquaculture will also benefit from approval of the new drug. According to industry figures, uncontrolled diseases cause around $100 million in losses in the catfish industry alone. Half of the reported disease cases were attributed to the three diseases this new drug can treat: bacterial gill disease and external columnaris disease of fish, and saprolegniasis on fish eggs.

Researchers at the USGS Upper Midwest Environmental Sciences Center (UMESC) in La Crosse, Wisc., developed the data that resulted in the approval for the drug, with financial support through the Federal-State Aquaculture Drug Approval Partnership Project. Dr. Michael Jawson, UMESC center director, said that this approval is a critical step forward in helping control diseases in commercially and publicly raised fishes. He noted that the broad use approval is unique and significant for U.S. aquaculture in that it covers two fish life stages eggs and fish of a number of cultured freshwater fish species for three separate diseases. Fish commonly afflicted with these diseases include trout, salmon, steelhead, channel catfish, and tilapia.

Rosalie Schnick, National Coordinator for Aquaculture New Animal Dr
'"/>

Contact: Randy K Hines
rkhines@usgs.gov
608-783-6451 x398
United States Geological Survey
13-Mar-2007


Page: 1 2

Related biology news :

1. First case of successful ovarian tissue transplantation between two, nonidentical sisters
2. First new multiple sclerosis gene found in 30 years
3. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
4. First all-African produced genetically engineered maize is resistant to maize streak virus
5. First baby is born after oocytes were matured in the lab and frozen
6. First confirmed common genetic risk factors for breast cancer
7. First demonstration of new hair follicle generation in an animal model
8. First research to show that diabetes damages DNA in mens sperm and may affect fertility
9. First demonstration of muscle restoration in an animal model of Duchenne muscular dystrophy
10. First systematic study of Chinas one-child policy reveals complexity, effectiveness
11. First international conference on self-healing materials

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, ... Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma ... Cancer Institute. The event is free and open to the public, but registration ...
Breaking Biology Technology:
Cached News: